DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology ...

With a diverse drug portfolio and a robust pipeline of future drugs to market, this big pharma brand will play a major role ...

BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...

As the demand for localized treatment options continues to rise ... Smart Pills Market Size By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), By Target Area (Esophagus, Small ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

Diagnosed in 2021, Perry Newman, who is originally from Englee, is fundraising to raise enough money to participate in a ...

Relief Therapeutics announces positive final results of RLF-TD011 trial in epidermolysis bullosa: Geneva Tuesday, November 12, 2024, 10:00 Hrs [IST] Relief Therapeutics Holding SA ...

Together, they handle about 235,500 cases per year—roughly 650 a day or one every two minutes—involving everything from drug ...

In severe cases, blisters can develop into chronic wounds or form in internal organs such as the mouth or esophagus, leading to painful ... wound care routine required by current treatments. The U.S.